IIT研究人员于2024年7月31日将前列腺癌症检测和病原体检测技术转让给HUMMSA生物技术公司和UNINO保健公司。 IIT researchers transferred prostate cancer detection and pathogen detection technologies to HUMMSA Biotech and UNINO Healthcare on July 31, 2024.

印度理工学院的研究人员将两种保健技术,即加尔各答的HIMMASA生物技术“前列腺癌症检测DNAAptamer”和孟买的UNINNO保健转让给HIMMASA生物技术“Photonic 芯片光谱生物传感器”,以探测病原体。 Indian Institutes of Technology (IIT) researchers transferred two healthcare technologies, "DNA Aptamer for Prostate Cancer Detection" to HUMMSA Biotech in Kolkata and "Photonic Chip-based Spectrometric Biosensor" for pathogen detection to UNINO Healthcare in Mumbai. 这些技术是在电子和信息技术部资助的纳米电子研究和应用网络项目下开发的,目的是及早发现前列腺癌和传染性病原体。 These technologies, developed under the Ministry of Electronics and Information Technology-funded Nanoelectronics Network for Research and Applications (NNetRA) project, aim to detect prostate cancer and infectious pathogens early. 技术转让活动于2024年7月31日在德里信息技术研究所举行。 The technology transfer event was held at IIT Delhi on July 31, 2024.